Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. [electronic resource]
Producer: 20110926Description: 495-500 p. digitalISSN:- 1095-6859
- Adult
- Aged
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- adverse effects
- Carcinoma, Squamous Cell -- drug therapy
- Cetuximab
- Disease-Free Survival
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Survival Rate
- Uterine Cervical Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.